I know there were a few comments made about the last presentation. And this one, no doubt, addresses them and simplifies further the message. So i see it as all good. The platform is the short term focus imo and a deal using the platform is the short term cash concept I feel. As for Genetech, they cannot not proceed in my view given what they are up to, of course, that is if it all works. So them extending will be huge. 2c minimum. We wait. But in the background is the holy grail, price that in if you dare but 5c at this time would not be unreasonable just for that.
And here we are t 4. Blue sky is a thing of the past it seems in biotech.
So this stock is cheap.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.30 |
Change
-0.025(1.89%) |
Mkt cap ! $755.3M | |||
| Open | High | Low | Value | Volume |
| $1.32 | $1.32 | $1.30 | $478.1K | 365.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $1.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.32 | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |